0001708138-20-000029.txt : 20200403 0001708138-20-000029.hdr.sgml : 20200403 20200403164934 ACCESSION NUMBER: 0001708138-20-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200401 FILED AS OF DATE: 20200403 DATE AS OF CHANGE: 20200403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Landry Robert E CENTRAL INDEX KEY: 0001585160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 20774167 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-04-01 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001585160 Landry Robert E 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP Finance CFO Common Stock 2020-04-01 4 S 0 23 478.97 D 24950 D Common Stock 2020-04-01 4 S 0 75 479.5 D 24875 D Common Stock 2020-04-01 4 S 0 87 481.91 D 24788 D Common Stock 2020-04-01 4 S 0 1 484.14 D 24787 D Common Stock 2020-04-01 4 S 0 23 486.27 D 24764 D Common Stock 2020-04-01 4 S 0 23 488.77 D 24741 D Common Stock 2020-04-01 4 S 0 61 489.46 D 24680 D Common Stock 2020-04-01 4 S 0 87 490.7 D 24593 D Common Stock 2020-04-01 4 S 0 64 492.61 D 24529 D Common Stock 2020-04-01 4 S 0 156 493.08 D 24373 D Common Stock 2020-04-01 4 M 0 2500 272.7 A 26873 D Common Stock 2020-04-01 4 F 0 1936 488.22 D 24937 D Common Stock 2020-04-01 4 M 0 2000 272.7 A 26937 D Common Stock 2020-04-01 4 F 0 1549 488.22 D 25388 D Common Stock 2020-04-01 4 M 0 1500 272.7 A 26888 D Common Stock 2020-04-01 4 F 0 1162 488.2 D 25726 D Common Stock 2020-04-02 4 M 0 3000 272.7 A 28726 D Common Stock 2020-04-02 4 F 0 2317 492.05 D 26409 D Common Stock 2020-04-02 4 S 0 139 483.51 D 26270 D Common Stock 2020-04-02 4 S 0 22 484.96 D 26248 D Common Stock 2020-04-02 4 S 0 62 485.63 D 26186 D Common Stock 2020-04-02 4 S 0 78 486.66 D 26108 D Common Stock 2020-04-02 4 S 0 91 487.29 D 26017 D Common Stock 2020-04-02 4 S 0 246 488.55 D 25771 D Common Stock 2020-04-02 4 S 0 128 489.39 D 25643 D Common Stock 2020-04-02 4 S 0 51 490.11 D 25592 D Common Stock 2020-04-02 4 S 0 85 491.72 D 25507 D Common Stock 2020-04-02 4 S 0 109 492.6 D 25398 D Common Stock 2020-04-02 4 S 0 146 493.54 D 25252 D Common Stock 2020-04-02 4 S 0 91 494.68 D 25161 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 75 shares of Company stock on April 1, 2020 at prices ranging from $479.06 to $479.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price. Represents volume-weighted average price of sales of 87 shares of Company stock on April 1, 2020 at prices ranging from $481.85 to $481.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price. Represents volume-weighted average price of sales of 61 shares of Company stock on April 1, 2020 at prices ranging from $489.44 to $489.48. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price. Represents volume-weighted average price of sales of 87 shares of Company stock on April 1, 2020 at prices ranging from $490.41 to $490.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price. Represents volume-weighted average price of sales of 64 shares of Company stock on April 1, 2020 at prices ranging from $492.07 to $492.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price. Represents volume-weighted average price of sales of 156 shares of Company stock on April 1, 2020 at prices ranging from $493.00 to $493.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price. Represents volume-weighted average price of sales of 139 shares of Company stock on April 2, 2020 at prices ranging from $483.28 to $483.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 62 shares of Company stock on April 2, 2020 at prices ranging from $485.01 to $485.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 78 shares of Company stock on April 2, 2020 at prices ranging from $486.62 to $486.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 91 shares of Company stock on April 2, 2020 at prices ranging from $487.04 to $487.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 246 shares of Company stock on April 2, 2020 at prices ranging from $488.02 to $488.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 128 shares of Company stock on April 2, 2020 at prices ranging from $489.07 to $489.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 85 shares of Company stock on April 2, 2020 at prices ranging from $491.64 to $491.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 109 shares of Company stock on April 2, 2020 at prices ranging from $492.37 to $492.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 146 shares of Company stock on April 2, 2020 at prices ranging from $493.01 to $493.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 91 shares of Company stock on April 2, 2020 at prices ranging from $494.00 to $494.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Form one of two /s/**Robert E. Landry 2020-04-03